<DOC>
	<DOCNO>NCT02684019</DOCNO>
	<brief_summary>Endoscopic retrograde cholangiopancreatography ( ERCP ) invasive long endoscopic procedure . It perform remote location continuum anesthetic depth , range conscious deep sedation lead general anesthesia . Propofol sedation ( ERCP ) procedures popular current technique generate controversy medical field . Propofol safely administer short half-life result short recovery time conventional sedation ( opioid and/or benzodiazepine ) make widely use sedation many gastrointestinal procedure include ERCP . However , narrow therapeutic window , level conscious sedation easily go deeply moderately deep sedation near general anesthesia . Therefore , propofol sole agent cause oversedation apnea . Depth sedation could estimate good target effect concentration propofol titrate use bispectral index monitoring device ( BIS ) .Targeting BIS within specific range ensure additional safety procedure . Scores 60-80 recommended sedation . Propofol requirement reduce addition adjuvant ( eg . Ketamine , Magnesium sulfate Dexmedetomidine ) . Most adjunct analgesic property opioid anesthetic sparing effect , without clinically significant respiratory depression . Dexmedetomidine , selective alpha 2 agonist ; sedative , amnestic , analgesic property . It useful addition propofol/remifentanil anesthetic combination reduce requirement intraoperatively help supplement analgesia postoperatively . Its combination propofol prove provide satisfactory anesthesia upper gastrointestinal ( GI ) ) endoscopy obstructive sleep apnea patient . Magnesium also act adjuvant analgesia due property calcium channel blocker N-methyl-D-aspartate antagonists .It suggest near ideal intravenous ( IV ) adjunct propofol/ remifentanil base total anesthesia gynaecology patient . Hypothesis study Magnesium sulfate propofol spar effect ERCP procedure guide BIS monitor efficient dexmedetomidine less cost complication together patient doctor satisfaction addition well patient outcome .</brief_summary>
	<brief_title>Goal Directed Propofol Sedation With Magnesium Sulphate Versus Dexmedetomidine ERCP Procedure</brief_title>
	<detailed_description>After Theodor Bilharz Research Institute ( TBRI ) Ethics Committee approval , sixty patient schedule ERCP procedure inform study write consent obtain . Patients allocate two group , thirty patient , Magnesium ( M ) Dexmedetomidine ( D ) . Group ( M ) receive 40 mg.kg-1 magnesium sulphate bolus follow IV infusion 10 mg.kg-1.h-1 . Group ( D ) receive dexmedetomidine bolus ( 1μg.kg-1 ) follow infusion 0.5μg.kg-1h-1 procedure . Randomization patient establish computer generate random number table utilize seal envelope technique . On arrival ERCP suit , two IV cannulae insert hand patient group . One isotonic saline infusion propofol administration preserve study drug administration . IV fluid start rate 8-12 ml.kg-1.h-1 continue throughout procedure . All patient premedicated intravenous pantoprazole 40mg ondansetron 8mg . Routine monitoring ECG , pulse oximetry , non-invasive blood pressure establish induction sedation . BIS three electrode sensor apply patient 's forehead use fronto-temporal montage monitoring level sedation . The baseline variable record document well continuous monitor documentation every 5 min first 30 min every 10 min till end procedure . Supplemental oxygen administer nasal prong 3 l.min-1 . The total duration procedure , define time take insertion endoscope removal , also document . Each study drug load 50 ml syrinx ( bolus infusion ) &amp; label `` study drug bolus '' `` study drug infusion '' . The identity constitute drug syringe reveal anesthetist handle patient observer record post procedure variable . Depending upon body weight , patient receive bolus study drug , dilute 50 ml saline ( direct IV ) follow infusion drug another 50 ml use syringe pump . Each bolus give rate drug infusion adjust anesthesia resident involve study . The study drug IV infusion administer use injector pump unidentified screen assure observer remain blind . For patient , bolus dose study drug administer slowly 10 min , mouth gag insertion patient positioning ( either lateral prone position ) follow induction propofol dose 0.5-1.5 mgkg-1 , target BIS 60-70.Once target BIS attain , infusion study drug start pre-adjusted rate ( discuss ) along propofol maintenance infusion start rate 3 mg/kg/hr adjust maintain BIS value 60-70.At end procedure , propofol study drug infusion stop . BIS value allow equilibrate 80 . Patients oropharynx thoroughly suction patient turn supine head tilt ( 15 degree ) , allow complete recovery eye open command , ability handle secretion , follow simple command , hemodynamic stability , maintain O2 saturation room air &gt; 95 % attainment BIS value &gt; 90 end point</detailed_description>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Magnesium Sulfate</mesh_term>
	<criteria>American Society Anesthesiologists ( ASA ) I , II III . Body mass index ( BMI ) ˂30 Patients schedule ERCP procedures 1 . Obesity ( BMI &gt; 30 ) 2 . Evidence hepatic encephalopathy , ascites . 3 . Sever renal , endocrine respiratory dysfunction . 4 . Atrioventricular conductance disturbance . 5 . Symptomatic bradycardia &lt; 35 bpm 6 . Hemodynamically unstable patient inotropic support . 7 . Neurological disorder 8 . Myasthenia gravis . 9 . Hypo/Hyperkalemia ( Potassium &lt; 3meq/l &gt; 5.5meq/l ) ( risk dysrhythmias ) . 10 . Chronic treatment calcium channel blocker magnesium 11 . Opioid analgesic abuse 12 . Allergy Propofol/ egg study drug . 13 . Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Endoscopic retrograde cholangiopancreatography</keyword>
	<keyword>sedation</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>propofol</keyword>
	<keyword>Magnesium sulphate</keyword>
	<keyword>Bispectral index monitoring</keyword>
</DOC>